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Abstract
The interaction between extrinsic factors and intrinsic signal strength governs thymocyte 
development, but the mechanisms linking them remain elusive. We report that mTORC1 couples 
microenvironmental cues with metabolic programs to orchestrate the reciprocal development of 
two fundamentally distinct T cell lineages, the αβ and γδ T cells. Developing thymocytes 
dynamically engage metabolic programs including glycolysis and oxidative phosphorylation, as 
well as mTORC1 signaling. Loss of RAPTOR-mediated mTORC1 activity impairs the 
development of αβ T cells but surprisingly promotes γδ T cell generation, associated with 
disrupted metabolic remodeling of oxidative and glycolytic metabolism. Mechanistically, we 
identify mTORC1-dependent control of reactive oxygen species (ROS) production as a key 
metabolic signal in mediating αβ and γδ T cell development, and perturbation of redox 
homeostasis impinges upon thymocyte fate decisions and mTORC1-associated phenotypes. 
Furthermore, single-cell RNA sequencing and genetic dissection reveal that mTORC1 links 
developmental signals from T cell receptors and NOTCH to coordinate metabolic activity and 
signal strength. Our results establish mTORC1-driven metabolic signaling as a decisive factor for 
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reciprocal αβ and γδ T cell development, and provide insight into metabolic control of cell 
signaling and fate decisions.
One Sentence Summary:
Development of αβ and γδ T cells requires coupling of environmental signals with metabolic and 
redox regulation by mTORC1.
INTRODUCTION
The thymus supports and guides the generation of a diverse repertoire of T cells from 
precursors migrating from the bone marrow (1). These thymocytes undergo a series of well-
characterized developmental processes and differentiate into two fundamentally distinct T 
cell lineages, the αβ and the γδ T cells, which serve critical immune functions (fig. S1A) (2, 
3). The divergence of αβ and γδ T cells occurs during thymocyte development around a 
stage known as double-negative (DN) 3, a crucial checkpoint in which the common 
progenitors undergo rearrangement of the T cell receptor (TCR) β, TCRγ, and TCRδ chains 
through integration of diverse thymic environmental signals (2, 3). For αβ T cell 
commitment, the expression of a functional pre-TCR after a productive rearrangement of the 
TCRβ chain, together with NOTCH and other signals, induces a proliferative response 
accompanied by differentiation into double-positive (DP) cells (4). In contrast, NOTCH 
signaling plays a less important role in γδ T cell development (5, 6). Discrete models, such 
as the instructive and stochastic models, have been proposed to describe the contribution of 
TCR-mediated signals to T cell lineage choices (3). More recent studies point to a key role 
of signal strength, in particular the ERK, EGR1, and ID3 signaling axis (ERK/EGR1/ID3), 
in determining lineage choices of thymic progenitors (7–10). However, the mechanisms 
linking extracellular stimuli to intrinsic signal strength remain elusive.
Emerging studies reveal metabolic reprogramming as a fundamental requirement for T cell 
function and adaptive immune responses (11, 12). For thymocyte development, evidence to 
date is mainly focused on the trophic effects of NOTCH and IL-7 on cell survival and 
growth (13, 14), but it remains unknown whether a specific metabolic signal is linked to 
lineage decisions and how metabolic programs interplay with immune signals. The 
mechanistic target of rapamycin (mTOR) is a central sensor that integrates immune signals 
and metabolic cues in orchestrating T cell function and fate (15). Emerging studies also 
highlight the involvement of mTOR signaling in thymocyte development and T-cell acute 
lymphoblastic leukemia (T-ALL) progression (16–18). However, whether mTOR signaling 
is implicated in αβ and γδ T cell lineage choices remains unknown.
Capitalizing on genetic deletion of RAPTOR, here we report that RAPTOR-dependent 
mTORC1 is a central regulator of T cell development and lineage choices by coordinating 
environmental cues and cellular metabolic programs. We find that developing thymocytes 
engage dynamic regulation of metabolic and mTORC1 activation. Loss of RAPTOR impairs 
αβ T cell development and reciprocally promotes γδ T cell development. mTORC1 
signaling and the transcription factor c-MYC (MYC) constitute a feed-forward loop that 
orchestrates thymocyte lineage choices. RAPTOR deficiency disrupts the balance of 
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oxidative and glycolytic metabolism, and results in excessive production of ROS that 
contributes to thymocyte lineage choices. Combining single-cell RNA sequencing (scRNA-
Seq) and transcriptome analysis and experimental validation, we revealed the key roles of 
mTORC1 in coordinating anabolic metabolism and signal strength. Our results establish 
metabolic control of signal strength and lineage choices as a fundamental mechanism in 
thymocyte development.
RESULTS
Metabolic and mTORC1 activities are dynamically regulated in T cell development
To understand metabolic regulation and requirements in developing thymocytes, we 
measured oxygen consumption rate (OCR) and extracellular acidification rate (ECAR), 
which respectively denote oxidative phosphorylation (OXPHOS) and glycolytic activities, in 
developing thymocytes. Specifically, we analyzed DN3 (the first stage with full T cell 
commitment (2)), DN4, and immature single-positive cells (ISP; the intermediate 
transitional stage between DN and DP stages), relative to quiescent DP thymocytes (fig. 
S1A). DN3 and ISP cells had the highest OCR at the basal level (Fig. 1A), whereas DN3 
cells displayed an even greater spare respiratory capacity (SRC), a measure of how 
effectively the electron transport chain can respond to energy demand, than ISP cells (Fig. 
1B). During the transition from DN3 to ISP cells, ECAR was progressively upregulated 
(Fig. 1C), indicating prominent upregulation of glycolysis in this process; this observation 
was confirmed by direct measurement of glycolytic activity (Fig. 1D). In contrast, DP cells 
markedly downregulated ECAR and glycolytic activity (Fig. 1, C and D). The dynamic 
regulation of OCR and ECAR in thymocyte subsets translated into a higher OCR/ECAR 
ratio in DN3 and DP cells (Fig. 1E), indicating the preferential use of oxidative metabolism 
over glycolysis by these cells.
Metabolic activity is contingent upon nutrient uptake and mTOR activation, a crucial 
regulator of anabolic metabolism (15). Compared with DN3 and DP cells, DN4 and ISP 
cells showed higher expression of CD98 and CD71, the respective amino acid and iron 
transporters (fig. S1, B and C), and increased cell size (fig. S1D). Accordingly, DN4 and ISP 
cells had higher phosphorylation of S6, indicative of greater mTORC1 activity (Fig. 1F). 
Collectively, these results indicate the dynamic regulation of metabolic and mTORC1 
activities in thymocyte development.
RAPTOR deficiency impairs DN to DP transition in αβ T cell development
To define the function of mTORC1 signaling in thymocyte development, we generated 
Rptorfl/flCd2-Cre (Rptor–/–) mice with the Cd2-Cre transgene (19) to initiate deletion of 
RAPTOR, an obligatory component of mTORC1, in early DN cells. Complete deletion of 
RAPTOR was observed in DN3 cells (fig. S2, A and B). RAPTOR deficiency resulted in 
greatly reduced thymocyte cellularity (Fig. 1G), including an approximately 10-fold 
reduction of DP cells as well as a considerable loss of CD4SP and CD8SP cells (Fig. 1H and 
fig. S2C). Consequently, T cell numbers in the spleen were significantly decreased (fig. 
S2D). RAPTOR deletion, however, caused a proportional increase of the DN compartment 
(Fig. 1H and fig. S2C), suggesting a possible blockade at the DN to DP transition.
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Hence, we performed detailed analysis of thymocyte subsets during the DN to DP transition. 
Although the frequency of Rptor–/– DN3 cells was reduced, their absolute number was 
elevated and this was in association with accumulation of total DN cells (Fig. 2A). In 
support of a role for RAPTOR in the DN to DP transition, Rptor–/– thymus contained 
significantly elevated frequency and cellularity of DN4 (Fig. 2A) and ISP cells (Fig. 2B). 
Next, we generated mixed bone marrow (BM) chimeras consisting of CD45.1+ (‘spike’) and 
CD45.2+ WT or Rptor–/– cells, and found that Rptor–/– but not WT or CD45.1+ cells showed 
increased DN and ISP cells, but reduced DP cells (Fig. 2, C and D). Finally, to directly 
assess the DN to DP transition, we co-cultured DN3 cells with OP9 stromal cells expressing 
the NOTCH ligand Delta-like 1 (OP9-DL1 cells), which represents a well-established in 
vitro system that models thymocyte development (5). In this system, Rptor–/– DN3 cells 
showed impaired capacity to progress into DP cells (Fig. 2E). Similarly, Rptor–/– ISP cells 
had defective development into DP cells (fig. S3A), consistent with the accumulation of ISP 
cells in vivo (Fig. 2B). Collectively, these results indicate that RAPTOR mediates the 
transition from DN to DP cells in a cell-autonomous manner.
To explore the mechanistic basis, we examined the underlying cellular processes. Cell 
apoptosis, as indicated by staining of the active form of caspase-3, was not altered in any of 
the Rptor–/– subsets analyzed (fig. S3B). BrdU incorporation assay showed that RAPTOR 
deletion impaired proliferation of ISP cells, but not that of DN3 or DN4 cells (fig. S3C). The 
proliferative expansion in DN4 and ISP cells is known to be preceded by a period of 
quiescence at the DN3 stage (2). In fact, DN3 thymocytes are a mixture of two populations: 
small TCRβ-unrearranged DN3-E (DN3a) cells and large TCRβ-rearranged DN3-L (DN3b) 
cells that are beginning the progression toward DP cells (20, 21), which is associated with 
upregulated CD27 expression (fig. S3D). Compared with DN3a cells, DN3b cells had 
increased mTORC1 activity (fig. S3E). Further, RAPTOR deficiency impaired upregulation 
of cell size and expression of CD71 and CD98 as early as in DN3b cells, and these defects 
were exacerbated in DN4 and, more strikingly, in ISP cells (fig. S3F). However, induction of 
intracellular TCRβ (icTCRβ) proceeded largely normal in DN3b cells (fig. S3G). Despite 
the small reduction in icTCRβ expression in Rptor–/– ISP cells (fig. S3G), transgenic 
expression of pre-rearranged OTII (MHC Class II-restricted) TCRαβ chains failed to rescue 
thymocyte developmental defects (Fig. 2F). These results indicate that RAPTOR deficiency 
does not affect thymocyte survival or pre-TCR induction, but prevents subsequent 
upregulation of cell size and nutrient receptors, ultimately leading to defective proliferation 
and differentiation of DN into DP cells.
Given that ISP cells represent a critical stage in the transition from DN to DP cells and are 
dysregulated in the absence of RAPTOR, we compared the transcriptional profiles of ISP 
cells from WT and Rptor–/– mice. Gene set enrichment analysis (GSEA) (22) revealed that 
many downregulated gene sets in Rptor–/– cells were related to metabolic programs, 
including cholesterol biosynthesis and the respiratory electron transport chain (fig. S4A), 
and real-time PCR analysis of lipogenic genes verified these hits (fig. S4B). Ingenuity 
Pathway Analysis (IPA) predicted the inhibition of MYC and SREBP factors (fig. S4C), 
which serve as crucial activators of anabolic metabolism (11, 12), in the absence of 
RAPTOR. Altogether, consistent with defective cell proliferation, growth, and nutrient 
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transporter expression (fig. S3), Rptor–/– ISP cells show impaired gene expression programs 
mediating lipogenic and other anabolic metabolism.
Loss of RAPTOR enhances γδ T cell development
Aside from the αβ T cell lineage, the γδ T cells are the other fundamentally distinct T cell 
lineage derived from the common thymocyte progenitors such as DN3 cells (2, 3). 
Surprisingly, Rptor–/– mice had significantly increased frequency and cellularity of TCRγδ+ 
T cells (Fig. 3A), resulting in a profoundly enhanced ratio of TCRγδ+ to TCRβ+ T cells (fig. 
S5A). Rptor–/– γδ T cells had efficient deletion of Rptor (fig. S5B), and this was associated 
with reduced cell size and lower CD71 and CD98 expression (fig. S5C). Rptor–/– γδ T cells 
had slightly reduced Ki67 expression (fig. S5D), but largely normal caspase-3 activity (fig. 
S5E), indicating that the increase in the γδ T cell compartment was unlikely due to altered 
proliferation or apoptosis. The alteration in γδ T cell development was also observed in the 
previously mentioned mixed BM chimeras, in which CD45.2+ Rptor–/– donor cells had 
much higher frequency of γδ T cells than WT cells (Fig. 3, B and C), indicating that 
RAPTOR loss promotes γδ T cell development in a cell-autonomous manner (i.e. not 
secondary to the loss of DP thymocytes given that normal thymic cellularity is provided by 
the CD45.1+ spike cells). This conclusion was further verified in the OP9-DL1 co-culture 
system, in which Rptor–/– DN3a cells showed increased generation of γδ T cells than their 
WT counterparts (fig. S5, F to H), even in the presence of CD45.1+ spike cells (fig. S5I). Of 
note, CD73 has been recently identified as an important marker to define γδ T cell 
commitment (23). Rptor–/– mice had a greatly elevated percentage and cellularity of the 
CD73+ population in thymic γδ T cells (Fig. 3, D and E). Additionally, the expression level 
of CD73 was increased in RAPTOR-deficient γδ T cells from both the thymus and spleen 
(Fig. 3F) as well as in those generated in vitro in the OP9-DL1 system (fig. S5, F and I), 
further supporting the role of RAPTOR in constraining γδ T cell development. To assess the 
involvement of RAPTOR in the TCR repertoire of γδ T cells, we examined the usage of 
diverse TCRγ chains in γδ T cells from the thymus (24, 25), and found that the composition 
of various Vγ chains was comparable between WT and Rptor–/– γδ T cells (fig. S5J). In line 
with this finding, RAPTOR-deficient γδ T cells had largely normal proportions of Vγ1.1+ 
and Vγ2+ subsets in the thymus (fig. S5, K and L). Taken together, our results indicate that 
RAPTOR deficiency promotes γδ T cell commitment without affecting the usage of TCRγ 
chains.
As an important regulator of mTORC1 signaling, the small G protein RHEB integrates 
different upstream signals from growth factor stimulation (15). However, Rhebfl/flCd2-Cre 
(Rheb–/–) mice had largely normal cellularity and frequencies of thymocyte subsets, 
including γδ T cells (fig. S6, A and B). On the other hand, even though RICTOR/mTORC2 
is required for αβ T cell development (26, 27), loss of RICTOR (Rictorfl/flCd2-Cre or 
Rictor–/– mice) did not impact the frequency or cellularity of γδ T cells (fig. S6C). Deletion 
of RICTOR in the Rptor–/– background further reduced the cellularity of total thymocytes, 
including γδ T cells (fig. S6C), but it had no substantial rescue effects on the frequency of 
γδ T cells (fig. S6C) or CD73 expression (fig. S6D). Collectively, RAPTOR-mTORC1 
exerts a unique and cell-autonomous role in constraining γδ T cell development.
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The reciprocal interplay between mTORC1 and MYC shapes thymocyte development
Given the link of mTORC1 to cell growth and anabolic metabolism in thymocyte 
development (fig. S3 and S4), we next explored the functional importance of selective 
metabolic programs in T cell development by targeting key transcriptional regulators. 
RAPTOR deficiency is predicted to downregulate SREBP1 and SREBP2 activities (fig. 
S4C), both of which are dependent upon the scaffold protein SCAP that is crucial for 
lipogenic metabolism and proliferation of T cells in the periphery (28). Deletion of SCAP 
(Scapfl/flCd2-Cre or Scap–/– mice) had no substantial effects on thymocyte populations (fig. 
S7A), with normal frequencies of DN subsets (fig. S7B), ISP cells (fig. S7C), and γδ T cells 
observed (fig. S7D). Another metabolic regulator frequently associated with mTORC1 
activity is the key glycolytic regulator HIF1α (29). HIF1α mediates metabolic 
reprogramming of TH17 cells (30) and effector CD8 T cells (31). While HIF1α expression is 
induced in developing thymocytes, deletion of HIF1α (Hif1afl/flCd2-Cre or Hif1a–/– mice) 
had no substantial impact on the frequencies of thymocyte subsets (fig. S7E) including γδ T 
cells (fig. S7F). These results indicate a dispensable role for SCAP-mediated lipogenesis and 
HIF1α function in thymocyte development.
The metabolic regulator MYC was among the top hits of the potential upstream regulators in 
RAPTOR-deficient cells (fig. S4C). Although MYC is required for thymocyte development, 
its functions and mechanisms in αβ and γδ T cell fate decisions remain uncertain (4, 32–
34). We found that deletion of MYC (Mycfl/flCd2-Cre or Myc–/– mice) greatly reduced 
cellularity of total thymocytes, and this was associated with reduced frequency of DP cells 
and increased frequency of DN cells (fig. S8A). Within the DN compartment, Myc–/– mice 
had increased frequency and number of DN3 cells (fig. S8, B and C). However, WT and 
Myc–/– DN3b cells had comparable induction of icTCRβ expression (fig. S8D), suggesting a 
largely normal β-selection. In contrast, Myc–/– mice had an elevated frequency of γδ T cells 
(Fig. 4, A and B) and ratio of TCRγδ+ to TCRβ+ cells (Fig. 4B). Despite undisturbed 
cellularity of γδ T cells in Myc–/– mice due to the drastic loss of total thymocytes (fig. S8E), 
Myc–/– γδ T cells had increased frequency and cellularity of the CD73+ population (Fig. 
4C) as well as higher levels of CD73 expression (Fig. 4D), supporting a role for MYC in 
restricting γδ T cell development.
We next investigated the interaction between RAPTOR and MYC in thymocyte 
development. First, we crossed Rptor–/– mice with GFP-MYC knockin mice (35) to track the 
dynamic regulation of MYC by means of GFP expression. WT DN3b cells upregulated 
expression of MYC, which was then downregulated in the DN4 stage (Fig. 4E). While 
Rptor–/– DN3a cells had normal GFPMYC expression, Rptor–/– DN3b cells had a modest 
reduction of GFP-MYC expression (Fig. 4E). This reduction was more pronounced in 
Rptor–/– DN4 cells (Fig. 4E), indicating that MYC acts downstream of RAPTOR. We next 
determined whether a reciprocal interaction exists; that is, whether MYC acts upstream of 
mTORC1 also. Indeed, Myc–/– DN3b and DN4 cells had markedly reduced phosphorylation 
of S6 and 4E-BP1 (Fig. 4, F and G). Therefore, mTORC1 and MYC constitute a reciprocal 
interaction loop in thymocyte development.
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RAPTOR modulates ROS production in fate decisions of DN3 cells
Given the dynamic metabolic regulation that occurs during T cell development (Fig. 1), we 
hypothesized that RAPTOR mediates metabolic reprogramming in DN3 cells, hence shaping 
their fate decisions. Compared with the WT counterparts, Rptor–/– cells had intact basal 
OCR (Fig. 5A) and expression of representative electron transport chain components (fig. 
S9A), albeit with a partial impairment in SRC (Fig. 5A). In contrast, Rptor–/– DN3 cells had 
reduced ECAR and glycolytic activity (Fig. 5B and fig. S9B). The increased ratio of OCR to 
ECAR in Rptor–/– DN3 cells (Fig. 5C) suggests disrupted control of bioenergetics and an 
increased reliance on oxidative metabolism to compensate for impaired glycolysis. 
Consistent with this idea, Rptor–/– DN3 cells, but not other subsets, had significantly 
increased ROS levels compared with WT counterparts (Fig. 5D and fig. S9C). The increased 
ROS induction was also observed in Rptor–/– γδ T cells (Fig. 5E). Other parameters 
associated with mitochondrial fitness, including mitochondrial mass and mitochondrial 
membrane potential, were comparable between WT and Rptor–/– cells (fig. S9, D and E). 
These results indicate that RAPTOR deficiency impairs metabolic remodeling and enhances 
ROS production in DN3 cells.
We next assessed whether directly modulating ROS production and metabolic activity 
affects fate choices of DN3 cells. First, we co-cultured DN3a cells with OP9-DL1 cells in 
the presence of galactose (Gal) and galactose oxidase (GAO), known promoters of ROS 
production (36). Gal/GAO significantly elevated the generation of γδ T cells (fig. S10A), 
concomitant with impaired generation of αβ T cells (fig. S10A). Second, we used 
dichloroacetate (DCA), an inhibitor of the mitochondrial enzyme pyruvate dehydrogenase 
kinase (PDK), to activate pyruvate dehydrogenase (PDH) and hence shift glycolysis to fuel 
OXPHOS in the mitochondria (37). DCA treatment promoted the generation of γδ T cells at 
the expense of αβ T cells (fig. S10B), associated with increased ROS production (fig. 
S10C). To exclude the potential effects of the pharmacological agents on OP9-DL1 cells, we 
next used a stromal cell-free system for in vitro thymocyte differentiation (38). Gal/GAO 
and DCA markedly promoted generation of γδ T cells along with reduction of αβ T cells 
(fig. S10D), indicating that ROS signaling targets thymocytes but not stromal cells in 
altering fate choices. Moreover, addition of the ROS scavenger N-acetyl-L-cysteine (NAC) 
or glutathione (GSH) significantly diminished and promoted the generation of γδ (Fig. 5F) 
and αβ T cells (Fig. 5G), respectively, without substantially altering total cellularity of the 
culture (fig. S10E). Using the stromal cell-free system, we also observed the blocking effects 
of NAC and GSH on the generation of γδ T cells and their CD73 expression levels (fig. S10, 
F and G). We next hypothesized that neutralizing ROS production could partially rescue the 
altered fate choices of Rptor–/– DN3a cells. In support of this, NAC treatment significantly, 
though not completely, suppressed the generation of γδ T cells derived from Rptor–/– DN3a 
cells (Fig. 5H), while reciprocally restoring the defective αβ T cell development and the 
altered ratio of γδ to αβ T cells (Fig. 5H). Moreover, the impaired transition of Rptor–/– 
DN3 cells to DN4 cells (indicated by the ratio of DN3 (CD25+CD44–) to DN4 (CD25–
CD44–) cells) was restored by NAC treatment (Fig. 5I). Of note, NAC treatment had no 
substantial effects on the reduced cellularity of Rptor–/– cells (Fig. 5J) or their survival (fig. 
S10H), indicating that ROS regulates lineage choices of DN3 cells independent of cell 
expansion. These results collectively indicate that mTORC1-dependent metabolic 
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remodeling in DN3 cells regulates the production of ROS as a metabolic signal in dictating 
lineage choices.
RAPTOR coordinates intrathymic signals in DN cells
Multiple immune and developmental cues, including TCR, NOTCH, and IL-7 signaling, 
mediate lineage choices of DN3 cells (2, 3). We next sought to determine their individual 
contributions to mTORC1 activation and function. DN3 cells from Rag1-deficient mice, 
which lack TCR rearrangement and thus TCR signaling, had markedly reduced 
phosphorylation of S6 (fig. S11A). Also, Rag1-deficient DN3a cells cultured with OP9-DL1 
cells were impaired to upregulate phosphorylation of S6 and 4E-BP1 (fig. S11B) compared 
to their WT counterparts, indicating that TCR signaling is required for mTORC1 activation. 
NOTCH is a pivotal factor in thymocyte development (3), however, the underlying 
mechanisms of NOTCH signaling in αβ and γδ T cell development remain to be fully 
understood (5, 6, 39, 40). Compared with OP9 cells (lacking NOTCH ligands), OP9-DL1 
cells induced greater phosphorylation of S6 and 4E-BP1 (fig. S11C) in DN3a cells, in a 
process independent of cell survival (fig. S11D). Moreover, rapamycin-mediated inhibition 
of mTORC1 activity enhanced γδ T cell development and reciprocally inhibited αβ T cell 
development (fig. S11E). Although IL-7 signaling has been recently shown to induce trophic 
effects in developing thymocytes (14), addition of IL-7 did not affect mTORC1 activity in 
DN3 cells (fig. S11F). Our results indicate mTORC1 integrates TCR and NOTCH signals to 
mediate fate choices of DN3 cells.
To understand RAPTOR-dependent signaling pathways underlying T cell lineage choices, 
we compared transcriptional profiles of pre-selection DN3a cells from WT and Rptor–/– 
mice. GSEA revealed that NF-κB signaling, which has been implicated in thymocyte 
development by mediating pre-TCR, NOTCH, and cytokine signaling (41–43), was 
aberrantly upregulated in RAPTOR-deficient DN3a cells (fig. S12A). Moreover, Rptor–/– 
cells showed a significant enrichment of NOTCH signaling (fig. S12A), which can activate 
NF-κB (43) as well as the ERK-MAPK signaling cascade (44). Additionally, we compared 
transcriptional profiles of WT and Rptor–/– γδ T cells, and GSEA also revealed significant 
enrichment of NF-κB signaling in the absence of RAPTOR (fig. S12B). In support of this 
finding, Rptor–/– γδ T cells had elevated phosphorylation of p65 at steady state and upon 
anti-TCRγδ stimulation (fig. S12C). Altogether, these results indicate that RAPTOR 
deficiency alters signal transduction in thymocyte development.
scRNA-Seq reveals RAPTOR-dependent signaling circuits in thymocyte lineage choices
Recent advances in scRNA-Seq have enabled an unbiased characterization of immune cell 
subpopulations during developmental processes and immune responses (45). We performed 
scRNA-Seq (46) to further investigate RAPTOR-dependent signaling pathways and 
functional modules underlying thymocyte lineage decisions. We analyzed 21,332 late-stage 
DN thymocytes (DN3-DN4; Lin–CD4–CD8–CD44–), including 7,345 WT and 13,987 
Rptor–/– cells, that passed quality control thresholds (Fig. 6A), and partitioned the cells into 
eight clusters in tSNE (‘t-distributed stochastic neighbor embedding’) plot through 
unsupervised clustering (Fig. 6B). To define the nature of these clusters, we calculated gene 
signature scores for DN3a cells based on the genes selectively expressed in DN3a cells in 
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the public datasets (47), and then overlaid expression of the DN3a gene signature attributed 
to each cell onto the tSNE visualization. Clusters 1, 5, and 8 showed much greater 
expression of the DN3a signature than the remaining clusters (Fig. 6, C and D). High levels 
of Il2ra and Ptcra, which encode CD25 and pre-TCRα respectively and are known to be 
abundantly expressed in DN3a cells compared with more mature thymocytes (47), were also 
found in clusters 1, 5, and 8 (fig. S12D). These results support the classification of clusters 
1, 5 and 8 as DN3a cells, whereas the remaining clusters likely represent post-selection 
thymocytes. Of note, Il2ra and Ptcra are target genes of NOTCH signaling, which is highly 
active in DN3a cells but downregulated after β-selection (47). Among these 3 DN3a 
clusters, cluster 5 showed increased expression of Il2ra, Ptcra, and additional NOTCH 
targets, including Notch1, Notch3, Dtx1, and Dtx3l (47) (fig. S12D) and, moreover, 
enhanced NOTCH signaling activity (fig. S12E). Interestingly, the majority of cells in 
cluster 5 were RAPTOR-deficient (Fig. 6E), while cluster 1 was dominated by WT cells, 
thereby verifying that deletion of RAPTOR rewires NOTCH signaling in DN3a cells. We 
next focused on transcriptional events in post-selection clusters. We found that the signature 
genes associated with pre-TCR signaling (i.e. genes induced in DN3b vs DN3a cells (47)) 
were highly enriched in cluster 4 (Fig. 6F and fig. S12F), which was predominantly 
comprised of RAPTOR-deficient cells, and, to a much lesser degree, in cluster 2, which was 
dominated by WT cells (Fig. 6E). In addition, the ERK signaling module was also higher in 
cluster 4 than in cluster 2 (Fig. 6F and fig. S12F), indicating the upregulation of TCR 
signaling in the absence of RAPTOR. In contrast, compared to cluster 2, cluster 4 showed 
lower signature scores of mTORC1 signaling, MYC targets, and glycolysis (Fig. 6G and fig. 
S12G), as well as expression of selective anabolic genes, including Ldha, Tpi1, Slc7a5, and 
Shmt2 (fig. S12H). Therefore, scRNA-Seq analysis suggests that RAPTOR coordinates TCR 
signaling and metabolic reprogramming in thymocyte development.
In further support of the enhanced γδ T cell development in RAPTOR-deficient mice, we 
found that the gene signature associated with γδ T cells (48) was upregulated in cluster 4, 
compared to cluster 2 (Fig. 6, H and I). To reconstruct the acquisition of γδ T cell fate over 
time, we analyzed our scRNA-Seq data using Monocle 2 (49), which provides pseudo-
temporal ordering of cells relative to developmental progression (‘pseudotime’). This 
allowed us to derive a relative developmental trajectory that revealed pronounced differences 
in the pseudotime assignment of the 8 clusters (Fig. 6J and fig. S13, A). Specifically, we 
found that cells with early pseudotime assignment were mainly restricted to clusters 1, 5 and 
8 (fig. S13A, blue arrow), consistent with the identification of these clusters as DN3a cells. 
This is further supported by the direct projection of the DN3a signature onto the pseudotime 
trajectory (fig. S13B), thereby corroborating our pseudotime analysis. In contrast, cells with 
late psedudotime were mostly enriched in cluster 4 and, to a lesser extent, in cluster 2 (fig. 
S13A, red arrows). Of note, the γδ T cell gene signature was highly enriched in cluster 4 
(fig. S13C), which was primarily comprised of Rptor–/– cells (fig. S13D). Altogether, these 
results support the enhanced gene expression and developmental progression along the γδ T 
cell lineage of RAPTOR-deficient T cells.
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RAPTOR tunes the strength of the ERK/EGR1/ID3 signaling pathway
The lineage decision of developing thymocytes is governed by various intrinsic factors, with 
TCR signal strength being particularly important (2, 3). The γδ T cell lineage choice is 
characterized by strong signal strength, especially in regards to the ERK/EGR1/ID3 
signaling axis, as opposed to αβ T cell development (7, 8). Our scRNA-Seq results suggest 
that RAPTOR coordinates metabolic reprogramming and signal strength in DN3 cells. 
Indeed, Rptor–/– DN3 cells had higher phosphorylation of ERK and expression of EGR1 and 
ID3 (Fig. 7, A to C) than did their WT counterparts. Ablation of ERK2 in a Rptor-deficient 
background did not substantially affect the reduction of DP thymocytes (Fig. 7D). However, 
it blocked the increased CD73+ γδ T cell population (Fig. 7E) and the elevated expression of 
CD73 (Fig. 7F), as compared to Rptor–/– mice. These results indicate that the increased 
signal strength due to RAPTOR deficiency contributes to γδ T cell development. In line 
with the intersection between RAPTOR/mTORC1 and MYC, Myc–/– DN3 cells displayed 
increased levels of ERK phosphorylation and ID3 expression (fig. S14, A and B). 
Interestingly, both MYC-deficient DN3a and DN3b cells had higher levels of ROS (fig. 
S14C), associated with increased expression of CD5 (fig. S14D). Furthermore, DCA, which 
altered the development of αβ and γδ T cells (fig. S10B), increased the expression of ID3 in 
DN3 cells co-cultured with OP9-DL1 cells (fig. S14E). The expression of CD73, which is 
induced by TCR-ERK signaling to promote γδ T cell commitment (9), was markedly 
enhanced by treatment with DCA (fig. S14F) or Gal/GAO (fig. S14G). Collectively, these 
results indicate that the interplay between mTORC1, MYC, and ROS metabolism shapes the 
activity of the ERK/EGR1/ID3 signaling axis and, therefore, the strength of TCR signals in 
dictating lineage choices of DN3 cells (fig. S15).
DISCUSSION
Despite the emerging interest in immunometabolism, our understanding of whether and how 
metabolic intermediates or pathways modulate immunity through signaling mechanisms 
remains limited. Here we report that mTORC1-mediated integration of metabolic and 
signaling activities dictates the lineage choices of αβ and γδ T cells, and identify mTORC1-
dependent control of ROS production as a key metabolic signal in this process. Such 
developmental function of mTORC1 signaling depends upon its interplay with MYC in a 
feed-forward loop, but not other metabolic regulators such as HIF1α and SCAP. Our 
findings indicate that regulation of metabolic rewiring and redox homeostasis by mTORC1 
occurs in the lineage-specifying stage, DN3 cells, which likely reflects the cell context-
specific nature of this control mechanism. These results point to metabolic processes 
constituting a fundamental mechanism that connects extrinsic signals with transcriptional 
events and fate decisions.
Recent extensive studies have advanced our understanding of metabolic reprogramming of T 
cell-mediated immune responses (11, 12). However, little is known about the metabolic 
programs in thymocyte development, although NOTCH and IL-7 have been shown to exert 
trophic effects in this process (13, 14). Here we found that DN3 cells predominately use 
OXPHOS over glycolysis, whereas ISP cells have high activities of both OXPHOS and 
glycolysis. In contrast, DP cells markedly downregulate these metabolic activities. The use 
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of distinct metabolic programs by developing thymocytes likely fulfills the bioenergenetic 
and signaling requirements of the underlying developmental processes. Of note, these 
dynamic metabolic programs are associated with differential regulation of mTORC1 activity. 
Loss of RAPTOR and mTORC1 activity disrupts anabolic metabolism that supports 
population expansion, but also results in dysregulated ROS production. Furthermore, 
perturbation of redox homeostasis impinges upon thymocyte fate decisions and mTORC1-
associated phenotypes. Specifically, enhancing or attenuating ROS production has a direct 
impact on αβ and γδ T cell development, and antioxidant treatment rescues, albeit 
incompletely, the differentiation defect of mTORC1-deficient thymocytes. These results 
reveal a selective role for redox regulation in mediating cell fate decisions downstream of the 
multifunctional kinase mTORC1, and establish metabolic signaling as a decisive factor for 
fate decisions of αβ and γδ T cells in thymocyte development.
Our scRNA-Seq analysis further highlights the interplay between TCR signaling and 
metabolic activity. Among DN3a cells, clusters dominated by Rptor–/– cells upregulate 
NOTCH signaling, while in post-selection cells, they upregulate TCR and ERK signaling but 
show dampened anabolic metabolism. Such unbiased analysis also shows the upregulation 
of γδ T cell gene signature in the Rptor–/–-dominant cluster, which is further supported by 
the late pseudotime assignment. We have also attempted to directly assess γδ T cell 
commitment using in vitro single-cell progenitor assay, but the proliferative defect in 
Rptor–/– cells prevents such analysis. Nonetheless, blocking excessive ERK signaling 
substantially rectifies the increased generation of committed γδ T cells and expression of 
CD73 in Rptor–/– cells, supporting our model that increased signal strength due to RAPTOR 
deficiency promotes γδ T cell development.
A feature of the adaptive immune system is the intertwining cycles of quiescence and 
activation that accompany developmental and functional progression of T lymphocytes 
through their lifespan. Thymic colonization of largely nondividing progenitor cells is 
followed by two waves of proliferation separated by a brief period of quiescence at the DN3 
stage required for TCRβ chain rearrangement (2). T cells return to quiescence at the DP 
stage, which allows for their TCRα chain rearrangement. This quiescent status is maintained 
by mature thymocytes and peripheral naïve T cells until encounter with cognate antigen. Our 
data suggest that RAPTOR-dependent mTORC1 activation and metabolic reprogramming 
drive the exit of DN3 cells from quiescence, as Rptor–/– T cells cannot upregulate cell size or 
trophic receptors. Moreover, RAPTOR-deficient thymocytes are less efficient in population 
expansion, but this defect is observed mainly in ISP cells. Given the intricate link between 
cell proliferation and differentiation (4), such proliferative defect likely contributes to the 
developmental blockade and accumulation of ISP cells. For DN3 and DN4 cells in Rptor–/– 
mice, although their proliferation is largely normal, they already exhibit defective expression 
of trophic receptors and signaling events. These results indicate that the impaired cycling of 
Rptor–/– ISP cells is likely a consequence, not the cause, of loss of RAPTOR-dependent 
metabolic reprogramming and quiescence exit. The dispensable role of SCAP, an important 
regulator of cell proliferation (28), in thymocyte development further supports this notion.
In summary, our study reveals that dynamic regulation of metabolic programs and mTORC1 
activity is required for thymocyte development. In the peripheral immune compartment, 
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mTOR signaling exerts discrete effects on the fate decisions of effector and memory CD8+ T 
cells (50), and effector and regulatory CD4+ T cells (51). Interestingly, metabolic 
remodeling used by lineage-committed mature T cells to drive cell fates and immune 
functions following antigen stimulation is also adopted by developing T cells to determine 
lineage commitment itself in response to developmental signals and microenvironmental 
cues. We provide further evidence that mTORC1 signaling intersects with MYC function 
and ROS regulation, and coordinates TCR and NOTCH signaling and anabolic metabolism 
in dictating thymocyte fates. Collectively, our study establishes mTORC1 signaling as a 
developmental checkpoint that links intrathymic environmental signals and metabolic 
programs to drive thymocyte development. Future work is warranted to further dissect cell 
context-dependent regulation and physiologic effects of metabolic and redox controls in 
immune system development and activation.
Materials and Methods
Study design
Genetically engineered mouse strains were used to assess the role of RAPTOR and 
metabolic pathways in regulating the fate decisions of T cell lineages in the thymus. Mice 6–
10 weeks old were used unless otherwise noted. The development of thymocytes was 
analyzed by various methods, including flow cytometry analysis, cell sorting, microarray, 
glucose uptake, Seahorse (for glycolysis and oxidative phosphorylation), glycolytic flux, 
immunoblot, real-time PCR, sequencing of TCRγ chains, and scRNA-Seq. Details are 
described in Supplementary Materials and Methods. The sample size and experimental 
replicates are indicated in the figure legends. Group sizes were determined based on 
published literatures with similar experiments.
Mice
C57BL/6, CD45.1+, Scapflox, Erk2flox, Cd2-Cre, and Rag1–/– mice were purchased from the 
Jackson Laboratory. Rptorflox, Rhebflox, Hif1aflox, Rictorflox, and Mycflox mice have been 
described previously (30, 52–55). Littermates (Cre– flox/flox and Cre+ non-floxed mice) 
were used as WT controls. Mice at 6–10 weeks old were used unless otherwise noted. All 
mice were kept in specific pathogen-free conditions in Animal Resource Center at St. Jude 
Children’s Research Hospital (SJCRH). Animal protocols were approved by Institutional 
Animal Care and Use Committee of SJCRH.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Fig. 1. Dynamic regulation of cell metabolism and mTORC1 activity and the requirement of 
RAPTOR in thymocyte development.
(A and B) OCR in thymocyte subsets under basal condition (A) or in response to the 
indicated mitochondrial inhibitors (Oligo, Oligomycin; FCCP, carbonyl cyanide p-
trifluoromethoxyphenylhydrazone; and Rot, Rotenone) (B). SRC, spare respiratory capacity 
(SRC of DN3 cells is shown). (C and D) Measurement of ECAR (C) and glycolytic activity 
(D) in freshly isolated thymocyte subsets. (E) Ratio of OCR to ECAR in thymocyte subsets. 
(F) Relative phosphorylation of S6 (mean fluorescence intensity (MFI) in DN3 cells is set to 
1) in thymocyte subsets. (G) Total thymocyte cellularity of WT and Rptor–/– mice. Each 
symbol represents an individual mouse (n = 8 each group). (H) Flow cytometry of 
thymocyte subsets in WT and Rptor–/– mice (left). Right, cellularity of the indicated 
thymocyte subsets (DN, CD4–CD8–; DP, CD4+CD8+; CD8SP, CD4–CD8+TCRβ+; and 
CD4SP, CD4+CD8–TCRβ+). Each symbol represents an individual mouse (WT, n = 7; 
Rptor–/–, n = 6). Data are mean ± s.e.m. ns, not significant; *P < 0.05, **P < 0.001, and 
***P < 0.0001. One-way analysis of variance (ANOVA) with Tukey test (A to E), or two-
tailed unpaired t-test (G, H). Data are combination of three independent experiments (A to 
E), or representative of at least ten independent experiments (F to H). Numbers indicate 
percentage of cells in gates.
Yang et al. Page 16
Sci Immunol. Author manuscript; available in PMC 2019 July 06.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Fig. 2. RAPTOR deficiency impairs the DN to DP transition in αβ T cell development.
(A) Flow cytometry of DN1–4 subsets (gated on lineage-negative DN thymocytes) in WT 
and Rptor–/– mice (left). Frequencies (middle) and cellularity (right) of DN subsets. Each 
symbol represents an individual mouse (WT, n = 6; Rptor–/–, n = 5). (B) Left, gating strategy 
for ISP cells (CD4– CD8+TCRβ–). Right, flow cytometry (upper panels) and frequency and 
cellularity (lower panels) of ISP cells in WT and Rptor–/– mice. Each symbol represents an 
individual mouse (WT, n = 9; Rptor–/–, n = 8). (C and D) Sublethally irradiated Rag1–/– 
mice were reconstituted with a 1:1 mixture of CD45.1+ BM and either CD45.2+ WT or 
Rptor–/– BM cells to generate mixed bone marrow chimeras. Flow cytometry of thymocyte 
subsets (C, upper panels) or ISP cells (D, upper panels) in CD45.2+ WT and Rptor–/– donor-
derived cells, or in CD45.1+ spike-derived cells (C and D, lower panels). (E) Expression of 
CD4 and CD8 on WT and Rptor–/– DN3 cells co-cultured with OP9-DL1 cells for 3 or 8 
days. (F) Flow cytometry of thymocyte subsets in WT OTII and Rptor–/– OTII mice (n = 4 
each group) (left). Right, cellularity of total thymocytes. Data are mean ± s.e.m. ns, not 
significant; *P < 0.0005, and **P < 0.0001. One-way ANOVA with Tukey test (A), two-
tailed Mann-Whitney test (B, frequency), or two-tailed unpaired t-test (B, cellularity). Data 
are representative of at least three independent experiments (A to F). Numbers indicate 
percentage of cells in quadrants or gates.
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Fig. 3. Loss of RAPTOR promotes γδ T cell development.
(A) Flow cytometry (left) of TCRγδ+ cells in WT and Rptor–/– thymocytes. Frequency 
(middle) and cellularity (right) of TCRγδ+ cells. Each symbol represents an individual 
mouse (WT, n = 6; Rptor–/–, n = 5). (B) Flow cytometry of TCRγδ+ cells derived from WT 
and Rptor–/– donor (CD45.2+, left) or spike (CD45.1+, right) cells in the reconstituted BM 
chimeras as described in Figure 2C. Flow cytometry of TCRγδ+ cells in WT and Rptor–/– 
donor-derived thymocytes in the reconstituted mixed BM chimeras. (C) Distribution of DP 
(left) and γδ T cells (right) between CD45.1+ and CD45.2+-derived cells in the mixed bone 
marrow chimeras generated as described in Figure 2C, after normalization against non-
deleting DN1 thymocytes. (D) Expression of CD73 and CD24 on CD4–CD8–TCRγδ+ 
thymocytes from WT and Rptor–/– mice. (E) Frequency (left) and cellularity (right) of 
CD73+ TCRγδ+ cells in D. Each symbol represents an individual mouse (n = 4 each group). 
(F) Expression of CD73 on TCRγδ+ cells in the thymus and spleen of WT and Rptor–/– 
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mice, with MFI plotted above graphs. Data are mean ± s.e.m. *P < 0.05, **P < 0.005, and 
***P < 0.0005. Two-tailed Mann-Whitney test (A and E for frequency analyses), one-tailed 
unpaired t-test (C), or two-tailed unpaired t-test (A and E for cellularity). Data are 
representative of at least three independent experiments (A to F). Numbers indicate 
percentage of cells in quadrants or gates.
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Fig. 4. Interplay between mTORC1 and MYC in developing thymocytes.
(A) Flow cytometry of TCRβ+ and TCRγδ+ cells in WT and Myc–/– thymocytes. (B) 
Frequency of TCRγδ+ cells (left) and the ratio of TCRγδ+ to TCRβ+ cells (right) in WT 
and Myc–/– thymocytes. Each symbol represents an individual mouse (n = 4 each group). 
(C) Expression of CD73 and CD24 on CD4– CD8–TCRγδ+ thymocytes from WT and 
Myc–/– mice (left). Frequency (middle) and cellularity (right) of CD73+ TCRγδ+ cells. Each 
symbol represents an individual mouse (WT, n = 5; Myc–/–, n = 4). (D) Expression of CD73 
on TCRγδ+ cells in the thymus and spleen of WT and Myc–/– mice, with MFI plotted above 
graphs. (E) Expression of GFP-MYC in thymocyte subsets of WT and Rptor–/– mice, with 
MFI plotted above graphs. (F and G) Plots of p-S6 (F) and p-4E-BP1 (G) in thymocyte 
subsets of WT and Myc–/– mice, with MFI plotted above graphs. Data are mean ± s.e.m. *P 
< 0.05, **P < 0.005, and ***P < 0.0005. Two-tailed Mann-Whitney test (B and C for 
frequency analyses), or two-tailed unpaired t-test (B for ratio analyses, and C for cellularity). 
Data are representative of at least three independent experiments (A to E), or two (F, G) 
independent experiments. Numbers indicate percentage of cells in quadrants or gates.
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Fig. 5. RAPTOR controls metabolic balance between glycolysis and OXPHOS, and production of 
ROS in fate determination of DN3 cells.
(A) OCR in WT and Rptor–/– DN3 cells under basal conditions or in response to the 
indicated mitochondrial inhibitors (SRC of WT and Rptor–/– cells is shown). (B) 
Measurement of ECAR in WT and Rptor–/– DN3 cells. (C) Ratio of OCR to ECAR in WT 
and Rptor–/– DN3 cells. (D and E) Analysis of ROS production in DN3 cells (D) and 
TCRγδ+ cells (E) from WT and Rptor–/– mice. (F and G) WT DN3a cells were co-cultured 
with OP9-DL1 cells in the absence or presence of NAC or GSH for 3 days, followed by 
analysis of CD4 and TCRγδ expression (F) and CD4 and CD8 expression (G). Right, 
numbers of TCRγδ+ (F) and CD4+CD8+ DP cells (G) in the culture (n = 3 each group). (H) 
WT and Rptor–/– DN3a cells were co-cultured with OP9-DL1 cells in the absence or 
presence of NAC for 5 days, followed by analysis of CD4 and TCRγδ expression (left). 
Right, fold change of the ratio of TCRγδ+ to CD4+ cells (WT without NAC treatment is set 
to 1), and frequencies of TCRγδ+ and CD4+ cells (n = 3 each group). (I) WT and Rptor–/– 
DN3a cells were co-cultured with OP9-DL1 cells in the absence or presence of NAC for 5 
days, followed by analysis of CD44 and CD25 expression (left). Right, fold change of the 
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ratio of CD25+CD44– (DN3) to CD25–CD44– (DN4) populations of WT and Rptor–/– cells 
without or with NAC treatment (WT without NAC treatment is set to 1). (J) Cellularity of 
total cells in H. Data are mean ± s.e.m. ns, not significant; *P < 0.05, **P < 0.01, and ***P 
< 0.0001. One-way ANOVA with Turkey test (A, F to J). Data are the combination of three 
independent experiments (A to C), or representative of at least three (D to J) independent 
experiments. Numbers indicate percentage of cells in quadrants or gates.
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Fig. 6. scRNA-Seq reveals that RAPTOR coordinates immune signaling and anabolic metabolism 
in thymocyte fate decisions.
(A) Single-cell RNA sequencing of WT and RAPTOR-deficient DN cells, followed by a 
tSNE visualization of the 21,332 single cells analyzed. (B) tSNE visualization of eight 
clusters partitioned by unsupervised clustering. (C) tSNE visualization of DN3a gene 
signature expressed by individual cells. (D) Association of different gene signatures with the 
eight single-cell clusters, with the relative over-representation of gene signatures for a 
specific cluster determined using one-tailed Mann-Whitney test. Clusters 1, 5, and 8 
contained DN3a cells, while the remaining clusters contained post-selection thymocytes. (E) 
Frequencies of WT and Rptor–/– cells in the different clusters. Clusters significantly 
enriched for presence of WT or Rptor–/– cells were marked. (F) Violin plots of signatures of 
pre-TCR and ERK signaling among the eight clusters. A violin plot combines the box plot 
and the local density estimation into a single display. The black bars and thin lines within the 
violin plots indicate the interquartile range (1st quantile – 3rd quantile) and the entire range 
of the data (up to 1.5 fold of interquartile range from 1st/3rd quantile), respectively, and the 
white dots in the center indicate the median values. (G) Violin plots of signatures of 
mTORC1 signaling, MYC targets, and glycolysis. (H and I) tSNE (H) and violin (I) plots of 
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γδ T cell gene signature. (J) Pseudotime densities for the 8 clusters. Data are mean ± s.e.m. 
*P < 0.05, and ***P < 0.0001. One-tailed Mann-Whitney test (D), Logistic regression (E), 
two-tailed Mann-Whitney test (F, G, I). Data are one experiment (WT, n = 2; Rptor–/–, n = 3; 
A to J).
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Fig. 7. RAPTOR tunes the strength of the ERK/EGR1/ID3 signaling axis in fate choices.
(A) Immunoblot analysis of p-ERK, EGR1, ID3 and β-ACTIN in WT and Rptor–/– DN3 
cells. (B and C) Plots of p-ERK (B) and expression of ID3 (C) in WT and Rptor–/– DN3 
cells, with MFI plotted in graphs. (D) Cellularity of CD4+CD8+ DP cells from the indicated 
mice. Each symbol represents an individual mouse (WT, n = 4; Rptor–/–, n = 3; Erk2–/–, n = 
4; Rptor–/–Erk2–/–, n = 4). (E) Flow cytometry of CD73 and CD24 expression on TCRγδ+ 
thymocytes in the indicated mice (left). Right, frequency and cellularity of CD73+ TCRγδ+ 
cells. Each symbol represents an individual mouse (WT, n = 4; Rptor–/–, n = 3; Erk2–/–, n = 
4; Rptor–/–Erk2–/–, n = 4). (F) Expression of CD73 on TCRγδ+ cells in E shown as the fold 
change (MFI on WT cells is set to 1). Data are mean ± s.e.m. *P < 0.05, and ***P < 0.0001. 
One-way ANOVA with Turkey test (D to F). Data are representative of at least three 
independent experiments (A to F).
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